- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00380289
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
We will be comparing the two most commonly used drugs to treat hypertension, atenolol and bendrofluazide, in patients for whom the drugs (and the doses to be used) are licenced.
We propose an initial open label pilot study of 10-12 patients to confirm final doses to be tested, the duration of therapy for optimum timing of the OGTT and tolerability of doses selected. The pilot study will also be used to confirm sample size calculations for the main study.The protocol for the pilot study will be identical to the main study, but there will not be a placebo phase and the treatment will not be blinded.
The main study will be double-blind, placebo controlled, cross-over study, of approximately 66 patients in which each patient receives in random order, 4 weeks treatment with either Bendrofluazide 5-10mg daily, Atenolol 50-100mg daily or combination of Bendrofluazide 2.5-5mg and Atenolol 25-50mg daily. There will be a forced titration from the lower to the higher dose stated half way through each dosing period. There will be a 1 month placebo wash-out between each dosing period.
At 0, 2 and 4 weeks of each treatment phase, patients will attend the Clinical Investigation Ward (CIW), fasting, for performance of an oral glucose tolerance test (OGTT). Blood will be drawn from an intravenous cannula, for the measurements of glucose and insulin at 0, 0.5, 1 and 2 hours.
Blood pressure will be measured at each study visit using an Omron machine. The patients will also be given a blood pressure machine to take home and will be asked to measure and record their blood pressure at least twice per week. If their blood pressure is under 110/70mmhg or over 160/110mmHg at any time or if the patient has symptoms e.g. headache or dizziness, the patient will be asked to contact study staff. If the blood pressure remains over 160/110 for two measurements, then another antihypertensive therapy may be commenced, or the patient withdrawn from the study. If blood pressure is < 110/70 mmHg with symptoms then a decision may be made to terminate their participation in the study.
Undersøgelsestype
Tilmelding
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Professor MJ Brown, MA MSC MD FRCP
- Telefonnummer: 01223 762577 (UK)
- E-mail: mjb14@medschl.cam.ac.uk
Undersøgelse Kontakt Backup
- Navn: Dr A Stears, MBBS BSc MRCP
- Telefonnummer: 01223 586865 (UK)
- E-mail: as659@medschl.cam.ac.uk
Studiesteder
-
-
-
Cambridge, Det Forenede Kongerige, CB2 2QQ
- Rekruttering
- Clinical Pharmacology Unit, Box 110, Level 3 ACCI, Addenbrookes Hospital
-
Kontakt:
- Mrs M Watts
- Telefonnummer: 01223 586865
- E-mail: mw363@medschl.cam.ac.uk
-
Kontakt:
- Dr A Stears, MBBS BSc MRCP
- Telefonnummer: 01223 586878
- E-mail: as659@medschl.cam.ac.uk
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Volunteers will be aged 18-75 years.
Hypertension- either
- untreated, BP 140-170/90-110
- treated for over 1 month with drugs other than beta blockers or diuretic and BP>140/85
- treated for over 1 month with drugs other than beta blockers or diuretic and BP<140/85 and patient willing to change medication for eight months.
Exclusion criteria:
- Any patient already taking thiazide diuretics or beta blockers in whom these drugs cannot be switched to alternative drugs with similar or better blood pressure control.
- Any patient who is intolerant of these medications will be excluded from the study.
- Patients with gout, asthma or any other contraindications to the study drugs will be excluded.
- Women of child bearing age not using contraception.
- Volunteers with heart failure, liver failure, renal failure, terminal illnesses (e.g. cancer)
- Volunteers not able to give informed consent
- Patients with diabetes
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Dobbelt
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
---|
Can the oral glucose tolerance test detect changes after 4 weeks treatment with thiazide diuretics or beta blockers or combination of the two?
|
Sekundære resultatmål
Resultatmål |
---|
Do patients show a similar change in glucose tolerance after thiazide or beta blocker therapy?
|
Does the combination of drugs cause a greater reduction in glucose tolerance than expected from the response to each drug taken alone?
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Professor MJ Brown, MA MSC MD FRCP, Addenbrookes Hosptal NHS Trust/ University of Cambridge
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- OGTT1
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Essentiel hypertension
-
Emory UniversityAfsluttetEssential Tremor | Essential Vocal Tremor | Essential Voice Tremor | Stemme tremor | Vokal TremorForenede Stater
-
Xiangya Hospital of Central South UniversityTilmelding efter invitation
-
University of MinnesotaRekrutteringEssential Tremor | Essential Tremor i øvre ekstremiteterForenede Stater
-
Syracuse UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)AfsluttetEssential Voice Tremor | Stemme tremor | Vokal Tremor | Essential Tremor of VoiceForenede Stater
-
Johns Hopkins Bloomberg School of Public HealthUniversity of Cape Town; Oxford Policy ManagementAfsluttetAmning | Familie planlægning | Essential nyfødtpleje | Uddannelse af Frontline Health WorkersIndien
-
University of MinnesotaRekruttering
-
Myles Mc LaughlinAfsluttet
-
InSightecHealth CanadaIkke rekrutterer endnuEssential Tremor | Neurologi
-
University of British ColumbiaAfsluttetLaryngeale sygdomme | Essential Tremor | Dyb hjernestimulation | Action Tremor | Essential Voice Tremor | Tremor, NerveCanada
-
The Cleveland ClinicRekrutteringEssential TremorForenede Stater
Kliniske forsøg med Thiazide and beta blocker
-
Medipol UniversityAfsluttetSlag | Balance | Funktionalitet | Motorisk billedevne | Mental kronometriKalkun
-
Institut de Recherches Cliniques de MontrealOttawa Hospital Research InstituteAfsluttet
-
St. John's Research InstitutePopulation Health Research Institute; Cadila PharnmaceuticalsAfsluttet
-
Hospices Civils de LyonRekruttering
-
Galenika AD BeogradMedicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)Afsluttet
-
Mayo ClinicAfsluttetErhvervsmæssig; Krampe(r)Forenede Stater
-
Chinese University of Hong KongTrukket tilbageMuskuloskeletale sygdomme eller tilstandeHong Kong
-
University of AlbertaAfsluttetAkut blindtarmsbetændelseCanada
-
University of Alabama at BirminghamAfsluttetTotal hofteproteseForenede Stater
-
AstraZenecaAfsluttetHjertefejl | Ventrikulær dysfunktion, venstreSverige